ロード中...
Endostatin improves cancer-associated systemic syndrome in a lung cancer model
Cancer-associated systemic syndrome (CASS) is characterized by a constellation of symptoms, including progressive weight loss, anemia, endocrine disorders, gastrointestinal dysfunction, muscle and adipose atrophy, hepatic peliosis and kidney failure. The present study assesses the effects of endosta...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467285/ https://ncbi.nlm.nih.gov/pubmed/26137006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3049 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|